KLHL38
gene geneOn this page
Also known as C8ORFK36
Summary
KLHL38 (kelch like family member 38, HGNC:34435) is a protein-coding gene on chromosome 8q24.13, encoding Kelch-like protein 38 (Q2WGJ6).
Predicted to enable ubiquitin-like ligase-substrate adaptor activity. Predicted to be involved in proteasome-mediated ubiquitin-dependent protein catabolic process. Predicted to be part of Cul3-RING ubiquitin ligase complex. Predicted to be active in cytoplasm.
Source: NCBI Gene 340359 — RefSeq curated summary.
At a glance
- GWAS associations: 31
- Clinical variants (ClinVar): 133 total
- MANE Select transcript:
NM_001081675
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34435 |
| Approved symbol | KLHL38 |
| Name | kelch like family member 38 |
| Location | 8q24.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | C8ORFK36 |
| Ensembl gene | ENSG00000175946 |
| Ensembl biotype | protein_coding |
| Entrez | 340359 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000325995, ENST00000684634
RefSeq mRNA: 1 — MANE Select: NM_001081675
NM_001081675
CCDS: CCDS43766
Canonical transcript exons
ENST00000684634 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001288008 | 123646909 | 123647014 |
| ENSE00003916302 | 123651577 | 123652927 |
| ENSE00003918098 | 123644442 | 123646028 |
| ENSE00003920627 | 123653586 | 123653801 |
Expression profiles
Bgee: expression breadth broad, 95 present calls, max score 96.63.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.5315 / max 123.2955, expressed in 96 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 94737 | 0.2634 | 59 |
| 94736 | 0.1591 | 41 |
| 94733 | 0.0375 | 9 |
| 94731 | 0.0258 | 8 |
| 94735 | 0.0230 | 13 |
| 94734 | 0.0105 | 5 |
| 205307 | 0.0074 | 4 |
| 94732 | 0.0048 | 2 |
Top tissues by expression
118 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skeletal muscle tissue | UBERON:0001134 | 96.63 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 95.67 | gold quality |
| gastrocnemius | UBERON:0001388 | 95.50 | gold quality |
| muscle of leg | UBERON:0001383 | 93.90 | gold quality |
| apex of heart | UBERON:0002098 | 90.25 | gold quality |
| muscle tissue | UBERON:0002385 | 87.46 | gold quality |
| heart left ventricle | UBERON:0002084 | 87.16 | gold quality |
| heart | UBERON:0000948 | 82.39 | gold quality |
| right atrium auricular region | UBERON:0006631 | 80.98 | gold quality |
| popliteal artery | UBERON:0002250 | 69.83 | gold quality |
| tibial artery | UBERON:0007610 | 69.77 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 69.31 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 67.31 | gold quality |
| mucosa of stomach | UBERON:0001199 | 66.39 | gold quality |
| left coronary artery | UBERON:0001626 | 65.20 | gold quality |
| right coronary artery | UBERON:0001625 | 65.18 | gold quality |
| thoracic aorta | UBERON:0001515 | 64.91 | gold quality |
| placenta | UBERON:0001987 | 64.83 | gold quality |
| ascending aorta | UBERON:0001496 | 64.36 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 60.37 | gold quality |
| myometrium | UBERON:0001296 | 59.99 | gold quality |
| body of uterus | UBERON:0009853 | 59.75 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 59.23 | gold quality |
| lower esophagus | UBERON:0013473 | 59.13 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 57.83 | gold quality |
| gall bladder | UBERON:0002110 | 57.80 | gold quality |
| urinary bladder | UBERON:0001255 | 56.26 | gold quality |
| prefrontal cortex | UBERON:0000451 | 54.24 | gold quality |
| stromal cell of endometrium | CL:0002255 | 53.93 | silver quality |
| fundus of stomach | UBERON:0001160 | 52.13 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-5061 | no | 3.66 |
| E-ANND-3 | no | 2.96 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- KLHL38 involvement in non-small cell lung cancer progression via activation of the Akt signaling pathway. (PMID:34050138)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | klhl38a | ENSDARG00000031383 |
| danio_rerio | klhl38b | ENSDARG00000040278 |
| mus_musculus | Klhl38 | ENSMUSG00000022357 |
| rattus_norvegicus | Klhl38 | ENSRNOG00000007896 |
Paralogs (54): KLHL13 (ENSG00000003096), KLHL20 (ENSG00000076321), KEAP1 (ENSG00000079999), KLHL42 (ENSG00000087448), KLHL22 (ENSG00000099910), KLHL4 (ENSG00000102271), KLHL2 (ENSG00000109466), KLHL5 (ENSG00000109790), BACH2 (ENSG00000112182), KLHL18 (ENSG00000114648), KLHL24 (ENSG00000114796), IVNS1ABP (ENSG00000116679), KLHL12 (ENSG00000117153), KLHL29 (ENSG00000119771), KBTBD7 (ENSG00000120696), KLHL7 (ENSG00000122550), KLHL31 (ENSG00000124743), KLHDC7B (ENSG00000130487), KLHL36 (ENSG00000135686), KLHL8 (ENSG00000145332), KLHL3 (ENSG00000146021), KLHL35 (ENSG00000149243), KLHL1 (ENSG00000150361), BACH1 (ENSG00000156273), KLHL40 (ENSG00000157119), KLHL10 (ENSG00000161594), KLHL21 (ENSG00000162413), KLHDC8A (ENSG00000162873), KBTBD8 (ENSG00000163376), KBTBD6 (ENSG00000165572), KLHL26 (ENSG00000167487), KLHL30 (ENSG00000168427), KBTBD2 (ENSG00000170852), KLHL6 (ENSG00000172578), KLHL15 (ENSG00000174010), KBTBD11 (ENSG00000176595), KLHDC7A (ENSG00000179023), KLHL28 (ENSG00000179454), KBTBD3 (ENSG00000182359), KLHL33 (ENSG00000185271)
Protein
Protein identifiers
Kelch-like protein 38 — Q2WGJ6 (reviewed: Q2WGJ6)
All UniProt accessions (1): Q2WGJ6
RefSeq proteins (1): NP_001075144* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000210 | BTB/POZ_dom | Domain |
| IPR006652 | Kelch_1 | Repeat |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
| IPR011705 | BACK | Domain |
| IPR015915 | Kelch-typ_b-propeller | Homologous_superfamily |
| IPR017096 | BTB-kelch_protein | Family |
| IPR030568 | KLHL38_BACK | Domain |
| IPR056737 | Beta-prop_ATRN-MKLN-like | Domain |
Pfam: PF00651, PF01344, PF07707, PF24981
UniProt features (16 total): sequence variant 6, repeat 6, domain 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q2WGJ6-F1 | 90.60 | 0.77 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 25 (showing top):
GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS, GOBP_PROTEIN_CATABOLIC_PROCESS, GOCC_TRANSFERASE_COMPLEX, GOBP_PROTEOLYSIS, GOCC_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX, GOCC_CUL3_RING_UBIQUITIN_LIGASE_COMPLEX, NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON, GOCC_UBIQUITIN_LIGASE_COMPLEX, chr8q24, GOMF_MOLECULAR_ADAPTOR_ACTIVITY, GOCC_INTRACELLULAR_PROTEIN_CONTAINING_COMPLEX, CUX1_TARGET_GENES, BPTF_TARGET_GENES, GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP
GO Biological Process (1): proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)
GO Molecular Function (2): ubiquitin-like ligase-substrate adaptor activity (GO:1990756), protein binding (GO:0005515)
GO Cellular Component (2): cytoplasm (GO:0005737), Cul3-RING ubiquitin ligase complex (GO:0031463)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| ubiquitin-dependent protein catabolic process | 1 |
| proteasomal protein catabolic process | 1 |
| enzyme-substrate adaptor activity | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| cullin-RING ubiquitin ligase complex | 1 |
Protein interactions and networks
STRING
574 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KLHL38 | NUDCD3 | Q8IVD9 | 528 |
| KLHL38 | NEURL1B | A8MQ27 | 520 |
| KLHL38 | STYXL2 | Q5VZP5 | 519 |
| KLHL38 | ACTR6 | Q9GZN1 | 494 |
| KLHL38 | CCDC141 | Q6ZP82 | 469 |
| KLHL38 | NUDCD2 | Q8WVJ2 | 463 |
| KLHL38 | SPSB3 | Q6PJ21 | 450 |
| KLHL38 | DLEC1 | Q9Y238 | 442 |
| KLHL38 | XKR9 | Q5GH70 | 428 |
| KLHL38 | UBR3 | Q6ZT12 | 414 |
| KLHL38 | TMEM68 | Q96MH6 | 414 |
| KLHL38 | PROCA1 | Q8NCQ7 | 406 |
| KLHL38 | ANKRD29 | Q8N6D5 | 393 |
| KLHL38 | FAM110B | Q8TC76 | 372 |
| KLHL38 | DYNLT4 | Q5JR98 | 370 |
IntAct
320 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRIM42 | KLHL38 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KLHL38 | KRT38 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KLHL38 | KRTAP5-9 | psi-mi:“MI:0915”(physical association) | 0.720 |
| MAGEA6 | KLHL38 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KLHL38 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP10-8 | KLHL38 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KLHL38 | KRT31 | psi-mi:“MI:0915”(physical association) | 0.720 |
| USHBP1 | KLHL38 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TRIM54 | KLHL38 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KLHL38 | BLZF1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KLHL38 | TRIM42 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT38 | KLHL38 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP5-9 | KLHL38 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP10-7 | KLHL38 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT31 | KLHL38 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KLHL38 | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KLHL38 | TRIM54 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KLHL38 | KRTAP10-8 | psi-mi:“MI:0915”(physical association) | 0.720 |
| BLZF1 | KLHL38 | psi-mi:“MI:0915”(physical association) | 0.720 |
BioGRID (103): KLHL38 (Two-hybrid), KLHL38 (Two-hybrid), KLHL38 (Two-hybrid), KLHL38 (Two-hybrid), KLHL38 (Two-hybrid), KLHL38 (Two-hybrid), KLHL38 (Two-hybrid), KLHL38 (Two-hybrid), KLHL38 (Two-hybrid), KLHL38 (Two-hybrid), KLHL38 (Two-hybrid), KLHL38 (Two-hybrid), KLHL38 (Two-hybrid), KLHL38 (Two-hybrid), KLHL38 (Two-hybrid)
ESM2 similar proteins: A2AAX3, A2AUC9, B3DIV9, D2HEW7, D3ZA50, D3ZZC3, E9QJ30, G3X9X1, O14682, O35709, O60662, Q08BL9, Q0D2A9, Q1LYM6, Q2TBA0, Q2WGJ6, Q3B7M1, Q4KLM4, Q53GT1, Q56A24, Q5EB39, Q5RCQ9, Q5RDY3, Q5RGB8, Q5U504, Q5U575, Q5ZJU2, Q66HD2, Q6DEL7, Q6DFF7, Q6GQU2, Q6NYM1, Q6Q7X9, Q6TFL4, Q6V595, Q8BRG6, Q8BWA5, Q8CA72, Q8IY47, Q8N4N3
Diamond homologs: A0JN76, A1L2U9, A1YPR0, B1WAZ8, B1WBS3, B1WBU4, B2RXF5, E1B932, G5E8B9, G5ED84, O14867, O15062, O15209, O35260, O43298, O88939, O93567, O95365, O95625, P28575, P41182, P41183, P97302, P97303, Q0IH98, Q0IJ29, Q0P4X6, Q0VCJ6, Q13105, Q13939, Q14526, Q1L8W0, Q1LYM6, Q2WGJ6, Q3B7N9, Q3SWU4, Q53G59, Q562B4, Q5R5N5, Q5TC79
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 81 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 23 | 25.1× | 3e-25 |
| Formation of the cornified envelope | 8 | 13.8× | 4e-06 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| morphogenesis of an epithelium | 7 | 37.0× | 1e-07 |
| intermediate filament organization | 8 | 29.6× | 7e-08 |
| epithelial cell differentiation | 7 | 18.9× | 8e-06 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
133 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 123 |
| Likely benign | 3 |
| Benign | 4 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
321 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:123646026:AACC:A | acceptor_loss | 1.0000 |
| 8:123646029:C:CC | acceptor_gain | 1.0000 |
| 8:123646029:C:CG | acceptor_loss | 1.0000 |
| 8:123647015:C:CA | acceptor_loss | 1.0000 |
| 8:123646025:TAAC:T | acceptor_gain | 0.9900 |
| 8:123646027:AC:A | acceptor_gain | 0.9900 |
| 8:123646028:CC:C | acceptor_gain | 0.9900 |
| 8:123646030:T:G | acceptor_loss | 0.9900 |
| 8:123646037:C:T | acceptor_gain | 0.9900 |
| 8:123646903:ACTC:A | donor_loss | 0.9900 |
| 8:123646904:CT:C | donor_loss | 0.9900 |
| 8:123646905:T:TC | donor_loss | 0.9900 |
| 8:123646906:C:CG | donor_loss | 0.9900 |
| 8:123646907:ACC:A | donor_loss | 0.9900 |
| 8:123646907:ACCTC:A | donor_gain | 0.9900 |
| 8:123646908:C:T | donor_loss | 0.9900 |
| 8:123646908:CCT:C | donor_gain | 0.9900 |
| 8:123646908:CCTCC:C | donor_gain | 0.9900 |
| 8:123647010:TAAAC:T | acceptor_gain | 0.9900 |
| 8:123647012:AAC:A | acceptor_gain | 0.9900 |
| 8:123647015:C:CC | acceptor_gain | 0.9900 |
| 8:123646024:GTAAC:G | acceptor_gain | 0.9800 |
| 8:123646036:CCAAA:C | acceptor_gain | 0.9800 |
| 8:123646744:T:TA | donor_gain | 0.9800 |
| 8:123646907:A:AC | donor_gain | 0.9800 |
| 8:123646907:ACCT:A | donor_gain | 0.9800 |
| 8:123646908:C:CC | donor_gain | 0.9800 |
| 8:123646908:CCTC:C | donor_gain | 0.9800 |
| 8:123647011:AAAC:A | acceptor_gain | 0.9800 |
| 8:123647011:AAACC:A | acceptor_gain | 0.9800 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000221852 (8:123653212 T>C), RS1000223787 (8:123651717 A>C,G), RS1000854489 (8:123649301 A>C,G), RS1001136823 (8:123654059 G>A), RS1001364539 (8:123648630 A>T), RS1001382079 (8:123653636 C>A,G,T), RS1001567050 (8:123649138 T>C), RS1001846660 (8:123650334 A>G,T), RS1002210402 (8:123648426 G>A,T), RS1002237669 (8:123653307 A>C), RS1002299171 (8:123650116 C>T), RS1002907419 (8:123651335 G>T), RS1003568810 (8:123651287 G>T), RS1003668666 (8:123647458 G>A,T), RS1004184683 (8:123644719 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
31 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002542_6 | Electrocardiographic traits | 1.000000e-07 |
| GCST006061_84 | Atrial fibrillation | 1.000000e-10 |
| GCST006979_368 | Heel bone mineral density | 6.000000e-13 |
| GCST007103_17 | QRS duration | 4.000000e-15 |
| GCST007104_9 | QRS duration | 6.000000e-19 |
| GCST007267_183 | Systolic blood pressure | 2.000000e-09 |
| GCST009921_4 | Carotid intima media thickness (mean) | 3.000000e-12 |
| GCST010321_123 | PR interval | 1.000000e-18 |
| GCST010796_1884 | Electrocardiogram morphology (amplitude at temporal datapoints) | 2.000000e-08 |
| GCST010796_1885 | Electrocardiogram morphology (amplitude at temporal datapoints) | 3.000000e-08 |
| GCST010796_1886 | Electrocardiogram morphology (amplitude at temporal datapoints) | 4.000000e-08 |
| GCST010796_1887 | Electrocardiogram morphology (amplitude at temporal datapoints) | 8.000000e-09 |
| GCST010796_1888 | Electrocardiogram morphology (amplitude at temporal datapoints) | 4.000000e-08 |
| GCST010796_1889 | Electrocardiogram morphology (amplitude at temporal datapoints) | 1.000000e-08 |
| GCST010796_1890 | Electrocardiogram morphology (amplitude at temporal datapoints) | 8.000000e-09 |
| GCST010796_1891 | Electrocardiogram morphology (amplitude at temporal datapoints) | 2.000000e-08 |
| GCST010796_1892 | Electrocardiogram morphology (amplitude at temporal datapoints) | 5.000000e-09 |
| GCST010796_385 | Electrocardiogram morphology (amplitude at temporal datapoints) | 3.000000e-16 |
| GCST010796_386 | Electrocardiogram morphology (amplitude at temporal datapoints) | 3.000000e-18 |
| GCST010796_387 | Electrocardiogram morphology (amplitude at temporal datapoints) | 5.000000e-18 |
| GCST010796_388 | Electrocardiogram morphology (amplitude at temporal datapoints) | 3.000000e-16 |
| GCST010796_389 | Electrocardiogram morphology (amplitude at temporal datapoints) | 2.000000e-14 |
| GCST010796_390 | Electrocardiogram morphology (amplitude at temporal datapoints) | 8.000000e-13 |
| GCST010796_391 | Electrocardiogram morphology (amplitude at temporal datapoints) | 6.000000e-12 |
| GCST010796_392 | Electrocardiogram morphology (amplitude at temporal datapoints) | 1.000000e-11 |
| GCST010796_393 | Electrocardiogram morphology (amplitude at temporal datapoints) | 9.000000e-12 |
| GCST010796_394 | Electrocardiogram morphology (amplitude at temporal datapoints) | 1.000000e-12 |
| GCST010796_395 | Electrocardiogram morphology (amplitude at temporal datapoints) | 8.000000e-14 |
| GCST010796_396 | Electrocardiogram morphology (amplitude at temporal datapoints) | 1.000000e-14 |
| GCST010796_397 | Electrocardiogram morphology (amplitude at temporal datapoints) | 5.000000e-14 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009270 | heel bone mineral density |
| EFO:0006335 | systolic blood pressure |
| EFO:0004462 | PR interval |
| EFO:0004327 | electrocardiography |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.